Please login to the form below

Not currently logged in
Email:
Password:

clinical trial

This page shows the latest clinical trial news and features for those working in and with pharma, biotech and healthcare.

Kymriah rejected in DLBCL - but NICE wants to keep talking about cost effectiveness

Kymriah rejected in DLBCL - but NICE wants to keep talking about cost effectiveness

This adds to Gilead’s advantage in clinical trial data, where its Yescarta looks to have significantly better rates of overall response rate and complete response.

Latest news

More from news
Approximately 8 fully matching, plus 1,047 partially matching documents found.

Latest Intelligence

  • Trust me, I’m from pharma Trust me, I’m from pharma

    It’s not a good look. Fortunately, better compliance with tightened regulations has meant that allegations of bribing doctors or misrepresenting clinical trial data are now extremely rare. ... Similarly, voice technology has a potential application in

  • What can pharma learn from the charity sector? What can pharma learn from the charity sector?

    Phase 3 clinical trial results are often communicated well by pharma companies but earlier phase results can be buried in jargon and technical language and are not widely shared.”.

  • Communication is the key to unlocking the potential of immuno-oncology Communication is the key to unlocking the potential of immuno-oncology

    On the flip side, there’s. a real danger of letting patients down if we don’t do more to support the unprecedented clinical advances with fit-for-purpose communications strategies. ... Our white paper looks at how Big Communication in IO affects

  • Brave real world? How healthcare communication needs to adapt Brave real world? How healthcare communication needs to adapt

    the stresses and strains of the real world. So how do we ensure that HCPs, regulators and patients understand and value data that has been collected outside a clinical trial? ... Second, we have to be clear when communicating the complexities and

  • Protecting patient privacy Protecting patient privacy

    Phase 2 of Policy 0070, which will require that life science companies provide anonymised copies of all of their clinical trial data, is coming down the line, albeit that currently there ... For clinical trial sponsors, this all adds up to the lowest

More from intelligence
Approximately 1 fully matching, plus 108 partially matching documents found.

Latest appointments

  • Aelix Therapeutics appoints Dr Thomas Hecht Aelix Therapeutics appoints Dr Thomas Hecht

    He said: “Aelix Therapeutics has reached a crucial milestone by enrolling the first patient in the phase I clinical trial and I’m thrilled to be joining the company at this

  • Belgium's TiGenix appoints Dr Gregory Gordon Belgium's TiGenix appoints Dr Gregory Gordon

    TiGenix has also appointed Annette Valles-Sukkar as associate director, clinical projects, and both she and Dr Gordon will report to the company’s chief medical officer Dr Marie Paule Richard. ... Meanwhile, Valles-Sukkar arrives at TiGenix from

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Bacterial infections focussed Nabriva Therapeutics has appointed Francesco Maria Lavino as its chief commercial officer ahead of the group’s phase III clinical trial for lefamulin - a potential new treatment for ... Lavino joins the Austrian

  • Multipharma launches Inceptua Medicines Access Multipharma launches Inceptua Medicines Access

    clinical trials of comparator sourcing, strategic planning, global depot solutions and clinical manufacturing. ... With this new addition Multipharma is poised to become a major global provider in the clinical trial services, pre-approval and unlicensed

  • Sam Agus takes up new role at Hansa Medical Sam Agus takes up new role at Hansa Medical

    With experience in medical strategy, multidisciplinary team leadership, medical marketing and clinical trial design, Agus’s therapy area expertise includes neurology, psychiatry, gastroenterology, women’s health and rare diseases.

More from appointments
Approximately 0 fully matching, plus 41 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics